68Ga-P16-093 PET/CT Imaging in the Salivary Gland

Summary

Prostate specific membrane antigen (PSMA) is a type II transmembrane protein and acts as a glutamate carboxypeptidase enzyme. It is first described in prostate cancer cell lines and later identified in various tissues, include salivary gland. This pilot study was designed to evaluate the diagnostic performance of 68Ga-P16-093 in primary sjogren's syndrome patients.

Timeline

Start

2023-10-01

Primary completion

2023-12-30

Completion

2024-03-31

Drugs

Indications